Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic corticosteroid prescriptions: Real-world US ADVANTAGE study

Authors:

Abstract
No abstract available
Funding Information
  • Regeneron Pharmaceuticals Inc
  • Sanofi Genzyme

This publication has 21 references indexed in Scilit: